Lv41
468 积分 2025-03-15 加入
LSD1 inhibitors for anticancer therapy: an updated patent review (2022–2025)
19天前
已完结
FAK inhibitors in Cancer, a patent review
19天前
已完结
FAK inhibitors in cancer, a patent review – an update on progress
19天前
已完结
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
1个月前
已完结
Structural basis of ER-associated protein degradation mediated by the Hrd1 ubiquitin ligase complex
1个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
1个月前
已完结
Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448)
1个月前
已完结
Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition
1个月前
已完结
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations
1个月前
已完结
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity
1个月前
已完结
皖公网安备34019202002308
